Skip to main content
Shenzhen Bioeasy Biotechnology Co., Ltd. logo

Shenzhen Bioeasy Biotechnology Co., Ltd. — Investor Relations & Filings

Ticker · 300942 ISIN · CNE100004C78 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 910 across all filing types
Latest filing 2025-09-15 Legal Proceedings Report
Country CN China
Listing Shenzhen Stock Exchange 300942

About Shenzhen Bioeasy Biotechnology Co., Ltd.

https://www.bioeasy.com

Shenzhen Bioeasy Biotechnology Co., Ltd. specializes in the development, production, and marketing of rapid testing solutions for food safety, clinical diagnosis, and animal health. The company provides a comprehensive portfolio of diagnostic products, including rapid test strips, enzyme-linked immunosorbent assay (ELISA) kits, and automated detection instruments. Its core focus areas include the detection of antibiotic residues, mycotoxins, pesticides, and foodborne pathogens in dairy, meat, seafood, and grain products. In the clinical sector, Bioeasy offers point-of-care testing (POCT) solutions for infectious diseases and chronic conditions. The company emphasizes research and development to deliver high-sensitivity, user-friendly diagnostic tools that meet international quality standards. Its products are utilized by food producers, regulatory agencies, and healthcare providers to ensure safety and quality control across the global supply chain.

Recent filings

Filing Released Lang Actions
国浩律师（深圳）事务所关于深圳市易瑞生物技术股份有限公司2025年第二次临时股东大会法律意见书
Legal Proceedings Report Classification · 100% confidence The document is a legal opinion letter from a law firm regarding the legality of the convening, procedures, attendance, and voting results of the 2025 second extraordinary general meeting of shareholders of Shenzhen Yirui Biotechnology Co., Ltd. It details the meeting notice, attendance, voting procedures, and results of various resolutions. The document does not contain financial statements or financial performance data but focuses on the legal compliance and validity of the shareholder meeting and its resolutions. This type of document is a legal proceedings report related to corporate governance and shareholder meetings, not an annual report, earnings release, or other financial report. Therefore, the appropriate classification is Legal Proceedings Report (LTR).
2025-09-15 Chinese
关于非独立董事辞职暨选举职工代表董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement from Shenzhen Yirui Biotechnology Co., Ltd. regarding the resignation of a non-independent director and the election of an employee representative director. It includes details about the resignation, the election process, and the qualifications of the newly elected director. There are no financial statements, earnings data, or detailed financial analysis present. The content focuses on changes in the company's board of directors and governance structure. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short (1321 characters), and it is not an announcement of a report publication but a direct announcement of management changes.
2025-09-15 Chinese
2025年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2025 second extraordinary general meeting (临时股东大会) of Shenzhen Yirui Biotechnology Co., Ltd. It includes information about the meeting time, attendance, voting results on various proposals, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the official voting results and decisions made by shareholders during the meeting. There is no indication that this is a full annual or interim report, audit report, or earnings release. The document is not a presentation or a proxy solicitation but an official announcement of voting results from a shareholders' meeting. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is sufficient and contains substantive voting data, not just a brief notice or a report publication announcement.
2025-09-15 Chinese
关于控股股东、实际控制人及其一致行动人权益变动触及1%整数倍暨减持计划实施完毕的公告
Major Shareholding Notification Classification · 100% confidence The document is an official announcement from Shenzhen Yirui Biotechnology Co., Ltd. regarding changes in shareholdings by the controlling shareholder and actual controller, specifically about their share reduction plan completion and the crossing of a 1% threshold in shareholding changes. It details the number of shares reduced, the percentage of total shares, the methods of reduction (centralized bidding and block trades), and confirms compliance with relevant securities laws and regulations. The document includes tables showing before and after shareholding percentages and confirms that the reduction plan has been fully implemented without affecting control of the company. There is no financial performance data, earnings information, or management discussion of financial results. The content focuses on shareholding changes by major shareholders and compliance with disclosure requirements. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document is not a report publication announcement or a regulatory filing fallback, as it provides detailed shareholding change information. Therefore, the correct classification is MRQ with high confidence.
2025-09-08 Chinese
关于控股股东、实际控制人及其一致行动人权益变动触及1%整数倍的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a formal announcement from Shenzhen Yirui Biotechnology Co., Ltd. regarding changes in shareholdings by the controlling shareholder, actual controller, and their concerted parties. It details the reduction in shares held, the percentage changes, and compliance with relevant securities laws and regulations. The content focuses on notifying the market and shareholders about the shareholding changes that have reached a 1% threshold. There are no financial statements, earnings data, or management discussion of financial results. The document is not a report but an official notification of shareholding changes, which fits the definition of a Major Shareholding Notification (MRQ). The document length is under 5,000 characters, but it contains detailed shareholding change data, not just a report publication announcement. Therefore, the correct classification is MRQ with high confidence.
2025-09-02 Chinese
募集资金管理制度
Capital/Financing Update Classification · 95% confidence The document is titled '募集资金管理制度' which translates to 'Fundraising Capital Management System' and is issued by Shenzhen Yirui Biotechnology Co., Ltd. It extensively details the management, use, supervision, and internal control of funds raised through stock issuance or equity securities. The document references relevant Chinese laws and stock exchange rules, and outlines procedures for the use, storage, and reporting of raised funds, including responsibilities of the board and management. It is a regulatory or internal governance document focused on capital management rather than a financial report, earnings release, or announcement. It does not contain financial statements or earnings data, nor is it a brief announcement or a presentation. It is a detailed policy or governance document related to capital management and compliance. Therefore, the most appropriate classification is 'Capital/Financing Update (CAP)' as it relates to updates and rules on fundraising and capital management.
2025-08-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.